data_2mie_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mie _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.635 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 11.3 p . . . . . 0 CA--C 1.551 1.007 0 CA-C-O 121.289 0.566 . . . . 2.3700000000000001 112.458 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -88.89 -0.42 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.181 1.92 . . . . 0.79000000000000004 112.272 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 p 47.35 43.46 15.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.954 -1.021 . . . . 1.96 112.148 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.68 -77.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 112.765 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.21 66.62 2.03 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.936 2.424 . . . . 1.75 112.868 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 2.0 p-10 33.98 61.36 1.91 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 124.633 1.173 . . . . 2.6200000000000001 113.98 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.6 Cg_endo -82.51 -62.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.45 2.1 . . . . 1.1499999999999999 109.647 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.9 mt -131.08 -39.51 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.832 -1.076 . . . . 2.2200000000000002 108.494 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.039 -0.982 . . . . 2.8100000000000001 110.581 176.153 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.842 0.83 . . . . 2.3700000000000001 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 10.3 Cg_endo -88.28 8.07 4.22 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.024 2.483 . . . . 0.79000000000000004 112.487 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 m 57.37 29.16 16.46 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.441 -0.799 . . . . 1.96 111.062 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 7' ' ' PRO . . . -99.8 -94.65 2.11 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.819 -0.705 . . . . 0.45000000000000001 112.499 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 6' ' ' GLY . 16.7 Cg_exo -68.85 56.26 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.529 2.819 . . . . 1.75 113.436 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 t-20 51.38 62.64 10.84 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.534 -0.757 . . . . 2.6200000000000001 112.077 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -87.14 -61.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.697 2.265 . . . . 1.1499999999999999 110.659 171.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.25 -21.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.578 -0.737 . . . . 2.2200000000000002 110.213 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.3 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.883 -0.599 . . . . 2.8100000000000001 109.937 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.478 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 p . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 122.066 0.936 . . . . 2.3700000000000001 111.022 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.9 Cg_endo -95.85 20.43 0.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.509 2.806 . . . . 0.79000000000000004 112.116 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.1 m 51.08 52.7 14.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.441 -0.8 . . . . 1.96 110.977 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.28 -82.2 0.15 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.457 -0.878 . . . . 0.45000000000000001 112.864 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.65 57.65 3.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.003 2.469 . . . . 1.75 111.963 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.1 p30 37.54 60.96 4.11 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 114.814 -1.084 . . . . 2.6200000000000001 113.369 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.0 Cg_exo -76.32 -53.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.957 1.771 . . . . 1.1499999999999999 109.757 173.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -135.01 -50.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.091 -0.959 . . . . 2.2200000000000002 109.041 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.758 -0.656 . . . . 2.8100000000000001 110.488 176.228 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.503 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 25.0 t . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.312 0.577 . . . . 2.3700000000000001 110.419 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 14.2 Cg_endo -99.35 28.26 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.701 2.934 . . . . 0.79000000000000004 112.09 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m 52.01 46.03 27.3 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.51 -0.768 . . . . 1.96 111.131 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.19 -84.02 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.818 -0.706 . . . . 0.45000000000000001 112.717 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 66.17 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.064 2.509 . . . . 1.75 112.817 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.5 p-10 37.13 55.46 3.44 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.629 1.172 . . . . 2.6200000000000001 113.784 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.3 Cg_exo -80.71 -69.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.269 1.979 . . . . 1.1499999999999999 110.893 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.73 20.61 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.23 1.014 . . . . 2.2200000000000002 108.369 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 35.6 t . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 114.713 -1.13 . . . . 2.8100000000000001 109.405 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.522 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 9.7 p . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.651 0.739 . . . . 2.3700000000000001 112.21 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 5.7 Cg_exo -79.89 6.69 5.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.528 2.152 . . . . 0.79000000000000004 112.436 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t 60.44 26.17 15.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.608 -0.724 . . . . 1.96 111.004 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.38 -89.26 1.89 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.876 -0.678 . . . . 0.45000000000000001 112.209 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.23 77.52 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.011 2.474 . . . . 1.75 112.989 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 5.6 p30 35.41 58.5 2.68 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.046 1.128 . . . . 2.6200000000000001 114.046 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.4 Cg_endo -88.73 -64.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.629 2.219 . . . . 1.1499999999999999 111.082 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.7 tt -120.71 11.09 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.795 -1.187 . . . . 2.2200000000000002 107.795 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 114.21 -1.359 . . . . 2.8100000000000001 110.118 -173.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.505 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 21.7 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.983 0.42 . . . . 2.3700000000000001 110.131 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -91.23 1.68 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.819 2.346 . . . . 0.79000000000000004 112.256 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.8 m 60.35 20.38 9.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.697 -0.683 . . . . 1.96 111.006 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.41 -80.96 0.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.967 -0.635 . . . . 0.45000000000000001 112.183 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.54 -82.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.38 2.053 . . . . 1.75 113.206 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.641 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 2.9 t-20 -112.05 -51.44 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.989 1.477 . . . . 2.6200000000000001 114.989 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 8' ' ' ASN . 17.4 Cg_exo -26.64 -69.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 124.622 3.548 . . . . 1.1499999999999999 114.528 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.14 57.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 2.2200000000000002 108.571 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' SER . 32.3 t . . . . . 0 C--N 1.323 -0.543 0 CA-C-N 115.275 -0.875 . . . . 2.8100000000000001 111.235 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.422 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 47.5 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.552 0.692 . . . . 2.3700000000000001 110.019 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.6 Cg_endo -98.89 17.27 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.839 3.026 . . . . 0.79000000000000004 112.545 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t 55.65 49.51 16.28 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.485 -0.78 . . . . 1.96 110.257 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.2 -96.54 0.66 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.473 -0.87 . . . . 0.45000000000000001 113.323 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.23 -73.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.127 2.551 . . . . 1.75 113.272 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.57 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 23.9 p-10 -157.96 54.35 0.76 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.846 0.684 . . . . 2.6200000000000001 112.846 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_endo -81.65 -65.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.862 1.708 . . . . 1.1499999999999999 110.38 171.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.2 tt -121.29 -9.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.4 -0.818 . . . . 2.2200000000000002 109.248 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 2.8100000000000001 110.962 -177.242 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.548 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 121.948 0.88 . . . . 2.3700000000000001 112.345 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 31.6 Cg_endo -101.91 14.91 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.498 2.799 . . . . 0.79000000000000004 112.328 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t 59.03 31.64 21.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.443 0.64 . . . . 1.96 109.988 -172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.43 -94.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.45000000000000001 113.157 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.65 -73.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.642 2.228 . . . . 1.75 112.451 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.607 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 p30 -154.87 53.22 0.83 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.156 0.428 . . . . 2.6200000000000001 112.156 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 7.9 Cg_exo -74.94 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.161 1.908 . . . . 1.1499999999999999 111.254 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.65 -32.2 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.217 -0.447 . . . . 2.2200000000000002 111.796 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 112.031 0.382 . . . . 2.8100000000000001 112.031 -173.619 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.606 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 7.9 p . . . . . 0 CA--C 1.554 1.127 0 N-CA-C 113.056 0.761 . . . . 2.3700000000000001 113.056 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 2.9 Cg_endo -82.92 -6.8 11.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.721 1.614 . . . . 0.79000000000000004 112.124 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.454 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 59.0 m 58.16 22.24 8.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.412 -0.813 . . . . 1.96 111.864 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.94 -89.09 1.56 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.875 -0.679 . . . . 0.45000000000000001 112.898 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.59 -79.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.074 2.516 . . . . 1.75 113.079 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.654 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.0 p30 -148.13 46.96 0.49 Allowed Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.939 0.718 . . . . 2.6200000000000001 112.939 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_exo -78.0 -69.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.921 1.747 . . . . 1.1499999999999999 110.778 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mt -109.67 -10.9 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.517 -0.92 . . . . 2.2200000000000002 108.517 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.45 -0.433 0 CA-C-N 114.91 -1.041 . . . . 2.8100000000000001 111.142 -177.704 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.605 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.7 p . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.696 0.628 . . . . 2.3700000000000001 112.696 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 18.0 Cg_endo -91.13 -6.35 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.804 1.669 . . . . 0.79000000000000004 112.401 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 46.43 41.89 10.0 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.139 -0.937 . . . . 1.96 112.157 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.52 -98.46 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.804 -0.712 . . . . 0.45000000000000001 113.129 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.17 -73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.964 3.109 . . . . 1.75 113.588 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.597 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 27.8 p-10 -156.94 55.17 0.96 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.001 0.371 . . . . 2.6200000000000001 112.001 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.7 Cg_exo -81.9 -68.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.281 1.988 . . . . 1.1499999999999999 110.991 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -116.37 -42.11 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.139 -0.482 . . . . 2.2200000000000002 110.547 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.234 0.251 0 CA-C-N 115.835 -0.621 . . . . 2.8100000000000001 111.46 -177.637 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.0 m80 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.469 -0.567 . . . . 6.7199999999999998 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -92.57 -92.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.66 -0.416 . . . . 1.95 110.966 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.635 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 11.3 p -149.53 50.12 0.75 Allowed Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 121.289 0.566 . . . . 2.3700000000000001 112.458 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -88.89 -0.42 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.181 1.92 . . . . 0.79000000000000004 112.272 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 p 47.35 43.46 15.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.954 -1.021 . . . . 1.96 112.148 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.68 -77.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 112.765 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.21 66.62 2.03 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.936 2.424 . . . . 1.75 112.868 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.492 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 2.0 p-10 33.98 61.36 1.91 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 124.633 1.173 . . . . 2.6200000000000001 113.98 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.6 Cg_endo -82.51 -62.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.45 2.1 . . . . 1.1499999999999999 109.647 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.9 mt -131.08 -39.51 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.832 -1.076 . . . . 2.2200000000000002 108.494 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.78 92.49 2.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.039 -0.982 . . . . 2.8100000000000001 110.581 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.424 -0.798 . . . . 3.8700000000000001 109.991 177.131 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.5 t60 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.346 -0.242 . . . . 6.7199999999999998 110.346 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -167.72 -87.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.703 0.287 . . . . 1.95 110.622 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p -152.07 54.77 1.37 Allowed Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 121.842 0.83 . . . . 2.3700000000000001 110.949 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 10.3 Cg_endo -88.28 8.07 4.22 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.024 2.483 . . . . 0.79000000000000004 112.487 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 m 57.37 29.16 16.46 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.441 -0.799 . . . . 1.96 111.062 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 7' ' ' PRO . . . -99.8 -94.65 2.11 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.819 -0.705 . . . . 0.45000000000000001 112.499 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 6' ' ' GLY . 16.7 Cg_exo -68.85 56.26 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.529 2.819 . . . . 1.75 113.436 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 t-20 51.38 62.64 10.84 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.534 -0.757 . . . . 2.6200000000000001 112.077 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -87.14 -61.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.697 2.265 . . . . 1.1499999999999999 110.659 171.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.25 -21.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.578 -0.737 . . . . 2.2200000000000002 110.213 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.3 m -158.44 148.17 19.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.883 -0.599 . . . . 2.8100000000000001 109.937 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.408 -0.806 . . . . 3.8700000000000001 110.193 172.409 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.731 0.301 . . . . 6.7199999999999998 110.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' C ' ' HD3' ' A' ' 4' ' ' PRO . 11.1 pt-20 -101.93 -27.9 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.313 -0.403 . . . . 1.95 111.288 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.478 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 p -135.51 62.02 46.94 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 122.066 0.936 . . . . 2.3700000000000001 111.022 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.9 Cg_endo -95.85 20.43 0.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.509 2.806 . . . . 0.79000000000000004 112.116 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.1 m 51.08 52.7 14.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.441 -0.8 . . . . 1.96 110.977 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.28 -82.2 0.15 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.457 -0.878 . . . . 0.45000000000000001 112.864 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.65 57.65 3.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.003 2.469 . . . . 1.75 111.963 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.1 p30 37.54 60.96 4.11 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 114.814 -1.084 . . . . 2.6200000000000001 113.369 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.0 Cg_exo -76.32 -53.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.957 1.771 . . . . 1.1499999999999999 109.757 173.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -135.01 -50.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.091 -0.959 . . . . 2.2200000000000002 109.041 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 m -70.15 95.97 1.03 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.758 -0.656 . . . . 2.8100000000000001 110.488 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.791 -0.623 . . . . 3.8700000000000001 109.939 177.798 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.7 m80 . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.56 0.219 . . . . 6.7199999999999998 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 29.0 tt0 -120.22 -136.86 0.33 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.035 -0.358 . . . . 1.95 110.035 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 25.0 t -135.36 61.41 44.42 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 121.312 0.577 . . . . 2.3700000000000001 110.419 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 14.2 Cg_endo -99.35 28.26 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.701 2.934 . . . . 0.79000000000000004 112.09 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m 52.01 46.03 27.3 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.51 -0.768 . . . . 1.96 111.131 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.19 -84.02 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.818 -0.706 . . . . 0.45000000000000001 112.717 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 66.17 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.064 2.509 . . . . 1.75 112.817 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.5 p-10 37.13 55.46 3.44 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.629 1.172 . . . . 2.6200000000000001 113.784 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.3 Cg_exo -80.71 -69.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.269 1.979 . . . . 1.1499999999999999 110.893 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.73 20.61 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.23 1.014 . . . . 2.2200000000000002 108.369 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 35.6 t -157.94 118.9 3.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.713 -1.13 . . . . 2.8100000000000001 109.405 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.214 -0.898 . . . . 3.8700000000000001 109.992 -178.54 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 63.4 t60 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.261 0.077 . . . . 6.7199999999999998 110.831 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -105.56 -93.42 0.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.626 -0.43 . . . . 1.95 111.124 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.522 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 9.7 p -157.39 55.94 1.03 Allowed Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 121.651 0.739 . . . . 2.3700000000000001 112.21 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 5.7 Cg_exo -79.89 6.69 5.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.528 2.152 . . . . 0.79000000000000004 112.436 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t 60.44 26.17 15.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.608 -0.724 . . . . 1.96 111.004 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.38 -89.26 1.89 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.876 -0.678 . . . . 0.45000000000000001 112.209 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.23 77.52 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.011 2.474 . . . . 1.75 112.989 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 5.6 p30 35.41 58.5 2.68 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.046 1.128 . . . . 2.6200000000000001 114.046 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.4 Cg_endo -88.73 -64.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.629 2.219 . . . . 1.1499999999999999 111.082 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.7 tt -120.71 11.09 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.795 -1.187 . . . . 2.2200000000000002 107.795 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -124.9 80.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.21 -1.359 . . . . 2.8100000000000001 110.118 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.006 -0.997 . . . . 3.8700000000000001 110.515 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.645 -0.502 . . . . 6.7199999999999998 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -121.32 -99.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.394 -0.366 . . . . 1.95 110.373 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.505 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 21.7 t -146.79 60.48 5.92 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 120.983 0.42 . . . . 2.3700000000000001 110.131 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -91.23 1.68 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.819 2.346 . . . . 0.79000000000000004 112.256 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.8 m 60.35 20.38 9.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.697 -0.683 . . . . 1.96 111.006 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.41 -80.96 0.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.967 -0.635 . . . . 0.45000000000000001 112.183 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.54 -82.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.38 2.053 . . . . 1.75 113.206 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.641 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 2.9 t-20 -112.05 -51.44 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.989 1.477 . . . . 2.6200000000000001 114.989 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 8' ' ' ASN . 17.4 Cg_exo -26.64 -69.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 124.622 3.548 . . . . 1.1499999999999999 114.528 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.14 57.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 2.2200000000000002 108.571 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 5' ' ' SER . 32.3 t -151.93 -40.58 0.11 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.275 -0.875 . . . . 2.8100000000000001 111.235 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 25.6 t-20 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.573 -0.727 . . . . 3.8700000000000001 109.967 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.0 m80 . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.47 0.176 . . . . 6.7199999999999998 110.649 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 3' ' ' VAL . 7.8 tp10 -96.85 -96.55 0.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.166 -0.214 . . . . 1.95 110.827 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.426 HG22 ' HG3' ' A' ' 2' ' ' GLU . 47.5 t -138.6 66.28 41.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.552 0.692 . . . . 2.3700000000000001 110.019 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.6 Cg_endo -98.89 17.27 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.839 3.026 . . . . 0.79000000000000004 112.545 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t 55.65 49.51 16.28 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.485 -0.78 . . . . 1.96 110.257 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.2 -96.54 0.66 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.473 -0.87 . . . . 0.45000000000000001 113.323 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.23 -73.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.127 2.551 . . . . 1.75 113.272 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.57 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 23.9 p-10 -157.96 54.35 0.76 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.846 0.684 . . . . 2.6200000000000001 112.846 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_endo -81.65 -65.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.862 1.708 . . . . 1.1499999999999999 110.38 171.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.2 tt -121.29 -9.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.4 -0.818 . . . . 2.2200000000000002 109.248 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p -99.79 66.2 1.38 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 2.8100000000000001 110.962 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.422 -0.799 . . . . 3.8700000000000001 110.004 179.03 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.515 ' HB2' ' HG3' ' A' ' 4' ' ' PRO . 83.8 m-70 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.989 -0.374 . . . . 6.7199999999999998 109.989 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' HG3' HG12 ' A' ' 3' ' ' VAL . 8.2 pt-20 -67.91 -48.38 66.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.33 0.863 . . . . 1.95 113.33 -169.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.548 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p -139.06 58.42 12.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 121.948 0.88 . . . . 2.3700000000000001 112.345 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 31.6 Cg_endo -101.91 14.91 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.498 2.799 . . . . 0.79000000000000004 112.328 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t 59.03 31.64 21.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.443 0.64 . . . . 1.96 109.988 -172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.43 -94.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.45000000000000001 113.157 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.65 -73.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.642 2.228 . . . . 1.75 112.451 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.607 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 p30 -154.87 53.22 0.83 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.156 0.428 . . . . 2.6200000000000001 112.156 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 7.9 Cg_exo -74.94 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.161 1.908 . . . . 1.1499999999999999 111.254 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.65 -32.2 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.217 -0.447 . . . . 2.2200000000000002 111.796 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 80.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.031 0.382 . . . . 2.8100000000000001 112.031 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.695 -0.669 . . . . 3.8700000000000001 109.649 172.082 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.2 m80 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.346 -0.242 . . . . 6.7199999999999998 110.346 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -105.13 -96.41 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.738 -0.385 . . . . 1.95 110.752 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.606 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 7.9 p -162.92 47.32 0.2 Allowed Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 113.056 0.761 . . . . 2.3700000000000001 113.056 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 2.9 Cg_endo -82.92 -6.8 11.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.721 1.614 . . . . 0.79000000000000004 112.124 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.454 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 59.0 m 58.16 22.24 8.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.412 -0.813 . . . . 1.96 111.864 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.94 -89.09 1.56 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.875 -0.679 . . . . 0.45000000000000001 112.898 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.59 -79.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.074 2.516 . . . . 1.75 113.079 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.654 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.0 p30 -148.13 46.96 0.49 Allowed Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.939 0.718 . . . . 2.6200000000000001 112.939 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_exo -78.0 -69.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.921 1.747 . . . . 1.1499999999999999 110.778 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mt -109.67 -10.9 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.517 -0.92 . . . . 2.2200000000000002 108.517 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p -100.06 72.47 1.68 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.91 -1.041 . . . . 2.8100000000000001 111.142 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 115.849 -0.614 . . . . 3.8700000000000001 110.177 176.757 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.483 -0.562 . . . . 6.7199999999999998 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.28 -88.43 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.997 -0.281 . . . . 1.95 111.117 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.605 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.7 p -164.31 45.03 0.12 Allowed Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 112.696 0.628 . . . . 2.3700000000000001 112.696 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 18.0 Cg_endo -91.13 -6.35 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.804 1.669 . . . . 0.79000000000000004 112.401 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 46.43 41.89 10.0 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.139 -0.937 . . . . 1.96 112.157 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.52 -98.46 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.804 -0.712 . . . . 0.45000000000000001 113.129 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.17 -73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.964 3.109 . . . . 1.75 113.588 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.597 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 27.8 p-10 -156.94 55.17 0.96 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.001 0.371 . . . . 2.6200000000000001 112.001 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.7 Cg_exo -81.9 -68.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.281 1.988 . . . . 1.1499999999999999 110.991 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -116.37 -42.11 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.139 -0.482 . . . . 2.2200000000000002 110.547 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -55.3 -55.85 26.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.835 -0.621 . . . . 2.8100000000000001 111.46 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HB2' ' HA ' ' A' ' 8' ' ' ASN . 94.3 m-20 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.36 -0.828 . . . . 3.8700000000000001 110.159 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 11.3 p . . . . . 0 CA--C 1.551 1.007 0 CA-C-O 121.289 0.566 . . . . 1.79 112.458 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -88.89 -0.42 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.181 1.92 . . . . 0.60999999999999999 112.272 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 p 47.35 43.46 15.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.954 -1.021 . . . . 1.4099999999999999 112.148 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.68 -77.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 112.765 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.21 66.62 2.03 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.936 2.424 . . . . 1.75 112.868 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 2.0 p-10 33.98 61.36 1.91 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 124.633 1.173 . . . . 2.0699999999999998 113.98 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.6 Cg_endo -82.51 -62.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.45 2.1 . . . . 0.75 109.647 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.9 mt -131.08 -39.51 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.832 -1.076 . . . . 1.75 108.494 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.039 -0.982 . . . . 2.2599999999999998 110.581 176.153 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.529 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.842 0.83 . . . . 1.79 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 10.3 Cg_endo -88.28 8.07 4.22 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.024 2.483 . . . . 0.60999999999999999 112.487 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 m 57.37 29.16 16.46 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.441 -0.799 . . . . 1.4099999999999999 111.062 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 7' ' ' PRO . . . -99.8 -94.65 2.11 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.819 -0.705 . . . . 0.45000000000000001 112.499 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 6' ' ' GLY . 16.7 Cg_exo -68.85 56.26 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.529 2.819 . . . . 1.75 113.436 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 t-20 51.38 62.64 10.84 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.534 -0.757 . . . . 2.0699999999999998 112.077 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -87.14 -61.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.697 2.265 . . . . 0.75 110.659 171.213 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.25 -21.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.578 -0.737 . . . . 1.75 110.213 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.3 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.883 -0.599 . . . . 2.2599999999999998 109.937 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.463 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 p . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 122.066 0.936 . . . . 1.79 111.022 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.9 Cg_endo -95.85 20.43 0.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.509 2.806 . . . . 0.60999999999999999 112.116 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.1 m 51.08 52.7 14.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.441 -0.8 . . . . 1.4099999999999999 110.977 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.28 -82.2 0.15 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.457 -0.878 . . . . 0.45000000000000001 112.864 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.65 57.65 3.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.003 2.469 . . . . 1.75 111.963 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.449 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.1 p30 37.54 60.96 4.11 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 114.814 -1.084 . . . . 2.0699999999999998 113.369 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.0 Cg_exo -76.32 -53.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.957 1.771 . . . . 0.75 109.757 173.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -135.01 -50.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.091 -0.959 . . . . 1.75 109.041 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.758 -0.656 . . . . 2.2599999999999998 110.488 176.228 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.493 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 25.0 t . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.312 0.577 . . . . 1.79 110.419 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 14.2 Cg_endo -99.35 28.26 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.701 2.934 . . . . 0.60999999999999999 112.09 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m 52.01 46.03 27.3 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.51 -0.768 . . . . 1.4099999999999999 111.131 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.19 -84.02 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.818 -0.706 . . . . 0.45000000000000001 112.717 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 66.17 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.064 2.509 . . . . 1.75 112.817 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.5 p-10 37.13 55.46 3.44 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.629 1.172 . . . . 2.0699999999999998 113.784 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.3 Cg_exo -80.71 -69.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.269 1.979 . . . . 0.75 110.893 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.73 20.61 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.23 1.014 . . . . 1.75 108.369 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 35.6 t . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 114.713 -1.13 . . . . 2.2599999999999998 109.405 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 9.7 p . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.651 0.739 . . . . 1.79 112.21 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 5.7 Cg_exo -79.89 6.69 5.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.528 2.152 . . . . 0.60999999999999999 112.436 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.418 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 22.6 t 60.44 26.17 15.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.608 -0.724 . . . . 1.4099999999999999 111.004 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.38 -89.26 1.89 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.876 -0.678 . . . . 0.45000000000000001 112.209 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.23 77.52 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.011 2.474 . . . . 1.75 112.989 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 5.6 p30 35.41 58.5 2.68 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.046 1.128 . . . . 2.0699999999999998 114.046 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.4 Cg_endo -88.73 -64.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.629 2.219 . . . . 0.75 111.082 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.7 tt -120.71 11.09 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.795 -1.187 . . . . 1.75 107.795 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 114.21 -1.359 . . . . 2.2599999999999998 110.118 -173.735 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.495 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 21.7 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.983 0.42 . . . . 1.79 110.131 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -91.23 1.68 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.819 2.346 . . . . 0.60999999999999999 112.256 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.8 m 60.35 20.38 9.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.697 -0.683 . . . . 1.4099999999999999 111.006 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.41 -80.96 0.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.967 -0.635 . . . . 0.45000000000000001 112.183 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.54 -82.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.38 2.053 . . . . 1.75 113.206 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.758 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 2.9 t-20 -112.05 -51.44 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.989 1.477 . . . . 2.0699999999999998 114.989 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.758 ' HD2' ' H ' ' A' ' 8' ' ' ASN . 17.4 Cg_exo -26.64 -69.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 124.622 3.548 . . . . 0.75 114.528 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.14 57.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 1.75 108.571 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' SER . 32.3 t . . . . . 0 C--N 1.323 -0.543 0 CA-C-N 115.275 -0.875 . . . . 2.2599999999999998 111.235 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 ' HA ' ' HB3' ' A' ' 9' ' ' PRO . 47.5 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.552 0.692 . . . . 1.79 110.019 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.6 Cg_endo -98.89 17.27 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.839 3.026 . . . . 0.60999999999999999 112.545 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t 55.65 49.51 16.28 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.485 -0.78 . . . . 1.4099999999999999 110.257 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.2 -96.54 0.66 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.473 -0.87 . . . . 0.45000000000000001 113.323 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.23 -73.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.127 2.551 . . . . 1.75 113.272 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.577 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 23.9 p-10 -157.96 54.35 0.76 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.846 0.684 . . . . 2.0699999999999998 112.846 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_endo -81.65 -65.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.862 1.708 . . . . 0.75 110.38 171.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.2 tt -121.29 -9.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.4 -0.818 . . . . 1.75 109.248 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 2.2599999999999998 110.962 -177.242 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 121.948 0.88 . . . . 1.79 112.345 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 31.6 Cg_endo -101.91 14.91 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.498 2.799 . . . . 0.60999999999999999 112.328 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t 59.03 31.64 21.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.443 0.64 . . . . 1.4099999999999999 109.988 -172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.43 -94.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.45000000000000001 113.157 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.65 -73.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.642 2.228 . . . . 1.75 112.451 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.611 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 p30 -154.87 53.22 0.83 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.156 0.428 . . . . 2.0699999999999998 112.156 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 7.9 Cg_exo -74.94 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.161 1.908 . . . . 0.75 111.254 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.65 -32.2 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.796 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 112.031 0.382 . . . . 2.2599999999999998 112.031 -173.619 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.612 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 7.9 p . . . . . 0 CA--C 1.554 1.127 0 N-CA-C 113.056 0.761 . . . . 1.79 113.056 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 2.9 Cg_endo -82.92 -6.8 11.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.721 1.614 . . . . 0.60999999999999999 112.124 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 59.0 m 58.16 22.24 8.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.412 -0.813 . . . . 1.4099999999999999 111.864 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.94 -89.09 1.56 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.875 -0.679 . . . . 0.45000000000000001 112.898 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.59 -79.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.074 2.516 . . . . 1.75 113.079 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.0 p30 -148.13 46.96 0.49 Allowed Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.939 0.718 . . . . 2.0699999999999998 112.939 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_exo -78.0 -69.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.921 1.747 . . . . 0.75 110.778 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mt -109.67 -10.9 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.517 -0.92 . . . . 1.75 108.517 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.45 -0.433 0 CA-C-N 114.91 -1.041 . . . . 2.2599999999999998 111.142 -177.704 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.7 p . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.696 0.628 . . . . 1.79 112.696 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 18.0 Cg_endo -91.13 -6.35 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.804 1.669 . . . . 0.60999999999999999 112.401 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 46.43 41.89 10.0 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.139 -0.937 . . . . 1.4099999999999999 112.157 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.52 -98.46 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.804 -0.712 . . . . 0.45000000000000001 113.129 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.17 -73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.964 3.109 . . . . 1.75 113.588 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.598 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 27.8 p-10 -156.94 55.17 0.96 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.001 0.371 . . . . 2.0699999999999998 112.001 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.7 Cg_exo -81.9 -68.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.281 1.988 . . . . 0.75 110.991 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -116.37 -42.11 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.139 -0.482 . . . . 1.75 110.547 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.234 0.251 0 CA-C-N 115.835 -0.621 . . . . 2.2599999999999998 111.46 -177.637 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.0 m80 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.469 -0.567 . . . . 6.0099999999999998 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -92.57 -92.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.66 -0.416 . . . . 1.95 110.966 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 11.3 p -149.53 50.12 0.75 Allowed Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 121.289 0.566 . . . . 1.79 112.458 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -88.89 -0.42 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.181 1.92 . . . . 0.60999999999999999 112.272 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 p 47.35 43.46 15.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.954 -1.021 . . . . 1.4099999999999999 112.148 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.68 -77.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 112.765 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.21 66.62 2.03 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.936 2.424 . . . . 1.75 112.868 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 2.0 p-10 33.98 61.36 1.91 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 124.633 1.173 . . . . 2.0699999999999998 113.98 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.6 Cg_endo -82.51 -62.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.45 2.1 . . . . 0.75 109.647 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.9 mt -131.08 -39.51 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.832 -1.076 . . . . 1.75 108.494 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.78 92.49 2.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.039 -0.982 . . . . 2.2599999999999998 110.581 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.424 -0.798 . . . . 3.25 109.991 177.131 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.5 t60 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.346 -0.242 . . . . 6.0099999999999998 110.346 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -167.72 -87.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.703 0.287 . . . . 1.95 110.622 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.529 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p -152.07 54.77 1.37 Allowed Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 121.842 0.83 . . . . 1.79 110.949 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 10.3 Cg_endo -88.28 8.07 4.22 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.024 2.483 . . . . 0.60999999999999999 112.487 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 m 57.37 29.16 16.46 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.441 -0.799 . . . . 1.4099999999999999 111.062 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 7' ' ' PRO . . . -99.8 -94.65 2.11 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.819 -0.705 . . . . 0.45000000000000001 112.499 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 6' ' ' GLY . 16.7 Cg_exo -68.85 56.26 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.529 2.819 . . . . 1.75 113.436 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 t30 51.38 62.64 10.84 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.534 -0.757 . . . . 2.0699999999999998 112.077 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -87.14 -61.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.697 2.265 . . . . 0.75 110.659 171.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.25 -21.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.578 -0.737 . . . . 1.75 110.213 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.3 m -158.44 148.17 19.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.883 -0.599 . . . . 2.2599999999999998 109.937 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.408 -0.806 . . . . 3.25 110.193 172.409 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.731 0.301 . . . . 6.0099999999999998 110.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' C ' ' HD3' ' A' ' 4' ' ' PRO . 11.1 pt-20 -101.93 -27.9 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.313 -0.403 . . . . 1.95 111.288 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.463 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 p -135.51 62.02 46.94 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 122.066 0.936 . . . . 1.79 111.022 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.9 Cg_endo -95.85 20.43 0.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.509 2.806 . . . . 0.60999999999999999 112.116 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.1 m 51.08 52.7 14.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.441 -0.8 . . . . 1.4099999999999999 110.977 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.28 -82.2 0.15 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.457 -0.878 . . . . 0.45000000000000001 112.864 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.65 57.65 3.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.003 2.469 . . . . 1.75 111.963 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.449 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.1 p30 37.54 60.96 4.11 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 114.814 -1.084 . . . . 2.0699999999999998 113.369 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.0 Cg_exo -76.32 -53.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.957 1.771 . . . . 0.75 109.757 173.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -135.01 -50.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.091 -0.959 . . . . 1.75 109.041 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 m -70.15 95.97 1.03 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.758 -0.656 . . . . 2.2599999999999998 110.488 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.791 -0.623 . . . . 3.25 109.939 177.798 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.7 m80 . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.56 0.219 . . . . 6.0099999999999998 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 29.0 tt0 -120.22 -136.86 0.33 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.035 -0.358 . . . . 1.95 110.035 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.518 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 25.0 t -135.36 61.41 44.42 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 121.312 0.577 . . . . 1.79 110.419 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 14.2 Cg_endo -99.35 28.26 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.701 2.934 . . . . 0.60999999999999999 112.09 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m 52.01 46.03 27.3 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.51 -0.768 . . . . 1.4099999999999999 111.131 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.19 -84.02 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.818 -0.706 . . . . 0.45000000000000001 112.717 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 66.17 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.064 2.509 . . . . 1.75 112.817 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.5 p-10 37.13 55.46 3.44 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.629 1.172 . . . . 2.0699999999999998 113.784 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.3 Cg_exo -80.71 -69.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.269 1.979 . . . . 0.75 110.893 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.73 20.61 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.23 1.014 . . . . 1.75 108.369 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 35.6 t -157.94 118.9 3.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.713 -1.13 . . . . 2.2599999999999998 109.405 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.214 -0.898 . . . . 3.25 109.992 -178.54 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 63.4 t60 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.261 0.077 . . . . 6.0099999999999998 110.831 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -105.56 -93.42 0.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.626 -0.43 . . . . 1.95 111.124 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 9.7 p -157.39 55.94 1.03 Allowed Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 121.651 0.739 . . . . 1.79 112.21 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 5.7 Cg_exo -79.89 6.69 5.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.528 2.152 . . . . 0.60999999999999999 112.436 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.418 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 22.6 t 60.44 26.17 15.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.608 -0.724 . . . . 1.4099999999999999 111.004 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.38 -89.26 1.89 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.876 -0.678 . . . . 0.45000000000000001 112.209 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.23 77.52 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.011 2.474 . . . . 1.75 112.989 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 5.6 p30 35.41 58.5 2.68 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.046 1.128 . . . . 2.0699999999999998 114.046 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.4 Cg_endo -88.73 -64.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.629 2.219 . . . . 0.75 111.082 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.7 tt -120.71 11.09 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.795 -1.187 . . . . 1.75 107.795 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -124.9 80.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.21 -1.359 . . . . 2.2599999999999998 110.118 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.006 -0.997 . . . . 3.25 110.515 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.645 -0.502 . . . . 6.0099999999999998 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -121.32 -99.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.394 -0.366 . . . . 1.95 110.373 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.495 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 21.7 t -146.79 60.48 5.92 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 120.983 0.42 . . . . 1.79 110.131 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -91.23 1.68 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.819 2.346 . . . . 0.60999999999999999 112.256 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.8 m 60.35 20.38 9.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.697 -0.683 . . . . 1.4099999999999999 111.006 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.41 -80.96 0.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.967 -0.635 . . . . 0.45000000000000001 112.183 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.54 -82.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.38 2.053 . . . . 1.75 113.206 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 1.5 t30 -112.05 -51.44 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.989 1.477 . . . . 2.0699999999999998 114.989 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.758 ' HD2' ' H ' ' A' ' 8' ' ' ASN . 17.4 Cg_exo -26.64 -69.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 124.622 3.548 . . . . 0.75 114.528 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.14 57.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 1.75 108.571 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' SER . 32.3 t -151.93 -40.58 0.11 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.275 -0.875 . . . . 2.2599999999999998 111.235 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 25.6 t-20 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.573 -0.727 . . . . 3.25 109.967 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.0 m80 . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.47 0.176 . . . . 6.0099999999999998 110.649 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 3' ' ' VAL . 7.8 tp10 -96.85 -96.55 0.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.166 -0.214 . . . . 1.95 110.827 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG23 ' HG3' ' A' ' 2' ' ' GLU . 47.5 t -138.6 66.28 41.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.552 0.692 . . . . 1.79 110.019 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.6 Cg_endo -98.89 17.27 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.839 3.026 . . . . 0.60999999999999999 112.545 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t 55.65 49.51 16.28 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.485 -0.78 . . . . 1.4099999999999999 110.257 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.2 -96.54 0.66 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.473 -0.87 . . . . 0.45000000000000001 113.323 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.23 -73.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.127 2.551 . . . . 1.75 113.272 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.577 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 23.9 p-10 -157.96 54.35 0.76 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.846 0.684 . . . . 2.0699999999999998 112.846 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_endo -81.65 -65.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.862 1.708 . . . . 0.75 110.38 171.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.2 tt -121.29 -9.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.4 -0.818 . . . . 1.75 109.248 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p -99.79 66.2 1.38 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 2.2599999999999998 110.962 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.422 -0.799 . . . . 3.25 110.004 179.03 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 4' ' ' PRO . 83.8 m-70 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.989 -0.374 . . . . 6.0099999999999998 109.989 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 3' ' ' VAL . 8.2 pt-20 -67.91 -48.38 66.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.33 0.863 . . . . 1.95 113.33 -169.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p -139.06 58.42 12.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 121.948 0.88 . . . . 1.79 112.345 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HG3' ' HB2' ' A' ' 1' ' ' HIS . 31.6 Cg_endo -101.91 14.91 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.498 2.799 . . . . 0.60999999999999999 112.328 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t 59.03 31.64 21.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.443 0.64 . . . . 1.4099999999999999 109.988 -172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.43 -94.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.45000000000000001 113.157 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.65 -73.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.642 2.228 . . . . 1.75 112.451 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.611 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 p30 -154.87 53.22 0.83 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.156 0.428 . . . . 2.0699999999999998 112.156 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 7.9 Cg_exo -74.94 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.161 1.908 . . . . 0.75 111.254 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.65 -32.2 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.796 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 80.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.031 0.382 . . . . 2.2599999999999998 112.031 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.695 -0.669 . . . . 3.25 109.649 172.082 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.2 m80 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.346 -0.242 . . . . 6.0099999999999998 110.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -105.13 -96.41 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.738 -0.385 . . . . 1.95 110.752 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.612 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 7.9 p -162.92 47.32 0.2 Allowed Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 113.056 0.761 . . . . 1.79 113.056 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 2.9 Cg_endo -82.92 -6.8 11.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.721 1.614 . . . . 0.60999999999999999 112.124 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 59.0 m 58.16 22.24 8.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.412 -0.813 . . . . 1.4099999999999999 111.864 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.94 -89.09 1.56 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.875 -0.679 . . . . 0.45000000000000001 112.898 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.59 -79.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.074 2.516 . . . . 1.75 113.079 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.0 p30 -148.13 46.96 0.49 Allowed Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.939 0.718 . . . . 2.0699999999999998 112.939 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_exo -78.0 -69.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.921 1.747 . . . . 0.75 110.778 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mt -109.67 -10.9 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.517 -0.92 . . . . 1.75 108.517 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p -100.06 72.47 1.68 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.91 -1.041 . . . . 2.2599999999999998 111.142 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 115.849 -0.614 . . . . 3.25 110.177 176.757 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.483 -0.562 . . . . 6.0099999999999998 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.28 -88.43 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.997 -0.281 . . . . 1.95 111.117 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.7 p -164.31 45.03 0.12 Allowed Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 112.696 0.628 . . . . 1.79 112.696 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 18.0 Cg_endo -91.13 -6.35 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.804 1.669 . . . . 0.60999999999999999 112.401 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 46.43 41.89 10.0 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.139 -0.937 . . . . 1.4099999999999999 112.157 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.52 -98.46 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.804 -0.712 . . . . 0.45000000000000001 113.129 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.17 -73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.964 3.109 . . . . 1.75 113.588 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.598 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 27.8 p-10 -156.94 55.17 0.96 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.001 0.371 . . . . 2.0699999999999998 112.001 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.7 Cg_exo -81.9 -68.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.281 1.988 . . . . 0.75 110.991 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -116.37 -42.11 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.139 -0.482 . . . . 1.75 110.547 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -55.3 -55.85 26.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.835 -0.621 . . . . 2.2599999999999998 111.46 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 8' ' ' ASN . 94.3 m-20 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.36 -0.828 . . . . 3.25 110.159 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 11.3 p . . . . . 0 CA--C 1.551 1.007 0 CA-C-O 121.289 0.566 . . . . 1.79 112.458 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -88.89 -0.42 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.181 1.92 . . . . 0.61 112.272 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 p 47.35 43.46 15.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.954 -1.021 . . . . 1.41 112.148 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.68 -77.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.546 -0.835 . . . . 0.45 112.765 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.21 66.62 2.03 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.936 2.424 . . . . 1.75 112.868 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 2.0 p-10 33.98 61.36 1.91 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 124.633 1.173 . . . . 2.07 113.98 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.6 Cg_endo -82.51 -62.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.45 2.1 . . . . 0.75 109.647 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.9 mt -131.08 -39.51 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.832 -1.076 . . . . 1.75 108.494 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.039 -0.982 . . . . 2.26 110.581 176.153 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.529 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p . . . . . 0 CA--C 1.545 0.776 0 CA-C-O 121.842 0.83 . . . . 1.79 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 10.3 Cg_endo -88.28 8.07 4.22 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.024 2.483 . . . . 0.61 112.487 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 m 57.37 29.16 16.46 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.441 -0.799 . . . . 1.41 111.062 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 7' ' ' PRO . . . -99.8 -94.65 2.11 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.819 -0.705 . . . . 0.45 112.499 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 6' ' ' GLY . 16.7 Cg_exo -68.85 56.26 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.529 2.819 . . . . 1.75 113.436 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 t-20 51.38 62.64 10.84 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.534 -0.757 . . . . 2.07 112.077 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -87.14 -61.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.697 2.265 . . . . 0.75 110.659 171.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.25 -21.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.578 -0.737 . . . . 1.75 110.213 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.3 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.883 -0.599 . . . . 2.26 109.937 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.463 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 p . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 122.066 0.936 . . . . 1.79 111.022 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.9 Cg_endo -95.85 20.43 0.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.509 2.806 . . . . 0.61 112.116 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.1 m 51.08 52.7 14.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.441 -0.8 . . . . 1.41 110.977 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.28 -82.2 0.15 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.457 -0.878 . . . . 0.45 112.864 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.65 57.65 3.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.003 2.469 . . . . 1.75 111.963 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.449 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.1 p30 37.54 60.96 4.11 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 114.814 -1.084 . . . . 2.07 113.369 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.0 Cg_exo -76.32 -53.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.957 1.771 . . . . 0.75 109.757 173.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -135.01 -50.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.091 -0.959 . . . . 1.75 109.041 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.758 -0.656 . . . . 2.26 110.488 176.228 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.493 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 25.0 t . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.312 0.577 . . . . 1.79 110.419 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 14.2 Cg_endo -99.35 28.26 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.701 2.934 . . . . 0.61 112.09 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m 52.01 46.03 27.3 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.51 -0.768 . . . . 1.41 111.131 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.19 -84.02 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.818 -0.706 . . . . 0.45 112.717 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 66.17 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.064 2.509 . . . . 1.75 112.817 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.5 p-10 37.13 55.46 3.44 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.629 1.172 . . . . 2.07 113.784 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.3 Cg_exo -80.71 -69.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.269 1.979 . . . . 0.75 110.893 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.73 20.61 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.23 1.014 . . . . 1.75 108.369 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 35.6 t . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 114.713 -1.13 . . . . 2.26 109.405 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.524 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 9.7 p . . . . . 0 CA--C 1.548 0.867 0 CA-C-O 121.651 0.739 . . . . 1.79 112.21 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 5.7 Cg_exo -79.89 6.69 5.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.528 2.152 . . . . 0.61 112.436 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.418 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 22.6 t 60.44 26.17 15.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.608 -0.724 . . . . 1.41 111.004 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.38 -89.26 1.89 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.876 -0.678 . . . . 0.45 112.209 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.23 77.52 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.011 2.474 . . . . 1.75 112.989 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 5.6 p30 35.41 58.5 2.68 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.046 1.128 . . . . 2.07 114.046 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.4 Cg_endo -88.73 -64.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.629 2.219 . . . . 0.75 111.082 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.7 tt -120.71 11.09 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.795 -1.187 . . . . 1.75 107.795 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 114.21 -1.359 . . . . 2.26 110.118 -173.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.495 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 21.7 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.983 0.42 . . . . 1.79 110.131 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -91.23 1.68 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.819 2.346 . . . . 0.61 112.256 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.8 m 60.35 20.38 9.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.697 -0.683 . . . . 1.41 111.006 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.41 -80.96 0.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.967 -0.635 . . . . 0.45 112.183 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.54 -82.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.38 2.053 . . . . 1.75 113.206 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.758 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 2.9 t-20 -112.05 -51.44 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.989 1.477 . . . . 2.07 114.989 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.758 ' HD2' ' H ' ' A' ' 8' ' ' ASN . 17.4 Cg_exo -26.64 -69.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 124.622 3.548 . . . . 0.75 114.528 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.14 57.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 1.75 108.571 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' SER . 32.3 t . . . . . 0 C--N 1.323 -0.543 0 CA-C-N 115.275 -0.875 . . . . 2.26 111.235 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 ' HA ' ' HB3' ' A' ' 9' ' ' PRO . 47.5 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.552 0.692 . . . . 1.79 110.019 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.6 Cg_endo -98.89 17.27 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.839 3.026 . . . . 0.61 112.545 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t 55.65 49.51 16.28 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.485 -0.78 . . . . 1.41 110.257 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.2 -96.54 0.66 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.473 -0.87 . . . . 0.45 113.323 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.23 -73.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.127 2.551 . . . . 1.75 113.272 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.577 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 23.9 p-10 -157.96 54.35 0.76 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.846 0.684 . . . . 2.07 112.846 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_endo -81.65 -65.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.862 1.708 . . . . 0.75 110.38 171.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.2 tt -121.29 -9.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.4 -0.818 . . . . 1.75 109.248 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 2.26 110.962 -177.242 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 121.948 0.88 . . . . 1.79 112.345 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 31.6 Cg_endo -101.91 14.91 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.498 2.799 . . . . 0.61 112.328 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t 59.03 31.64 21.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.443 0.64 . . . . 1.41 109.988 -172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.43 -94.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.45 113.157 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.65 -73.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.642 2.228 . . . . 1.75 112.451 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.611 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 p30 -154.87 53.22 0.83 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.156 0.428 . . . . 2.07 112.156 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 7.9 Cg_exo -74.94 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.161 1.908 . . . . 0.75 111.254 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.65 -32.2 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.796 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 112.031 0.382 . . . . 2.26 112.031 -173.619 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.612 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 7.9 p . . . . . 0 CA--C 1.554 1.127 0 N-CA-C 113.056 0.761 . . . . 1.79 113.056 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 2.9 Cg_endo -82.92 -6.8 11.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.721 1.614 . . . . 0.61 112.124 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 59.0 m 58.16 22.24 8.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.412 -0.813 . . . . 1.41 111.864 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.94 -89.09 1.56 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.875 -0.679 . . . . 0.45 112.898 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.59 -79.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.074 2.516 . . . . 1.75 113.079 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.0 p30 -148.13 46.96 0.49 Allowed Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.939 0.718 . . . . 2.07 112.939 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_exo -78.0 -69.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.921 1.747 . . . . 0.75 110.778 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mt -109.67 -10.9 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.517 -0.92 . . . . 1.75 108.517 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.45 -0.433 0 CA-C-N 114.91 -1.041 . . . . 2.26 111.142 -177.704 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.7 p . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.696 0.628 . . . . 1.79 112.696 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 18.0 Cg_endo -91.13 -6.35 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.804 1.669 . . . . 0.61 112.401 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 46.43 41.89 10.0 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.139 -0.937 . . . . 1.41 112.157 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.52 -98.46 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.804 -0.712 . . . . 0.45 113.129 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.17 -73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.964 3.109 . . . . 1.75 113.588 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.598 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 27.8 p-10 -156.94 55.17 0.96 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.001 0.371 . . . . 2.07 112.001 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.7 Cg_exo -81.9 -68.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.281 1.988 . . . . 0.75 110.991 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -116.37 -42.11 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.139 -0.482 . . . . 1.75 110.547 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.234 0.251 0 CA-C-N 115.835 -0.621 . . . . 2.26 111.46 -177.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.0 m80 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.469 -0.567 . . . . 6.01 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -92.57 -92.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.66 -0.416 . . . . 1.95 110.966 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 11.3 p -149.53 50.12 0.75 Allowed Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 121.289 0.566 . . . . 1.79 112.458 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -88.89 -0.42 6.36 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.181 1.92 . . . . 0.61 112.272 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.8 p 47.35 43.46 15.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.954 -1.021 . . . . 1.41 112.148 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.68 -77.09 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.546 -0.835 . . . . 0.45 112.765 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.21 66.62 2.03 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.936 2.424 . . . . 1.75 112.868 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 2.0 p-10 33.98 61.36 1.91 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 124.633 1.173 . . . . 2.07 113.98 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.6 Cg_endo -82.51 -62.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.45 2.1 . . . . 0.75 109.647 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.9 mt -131.08 -39.51 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.832 -1.076 . . . . 1.75 108.494 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -73.78 92.49 2.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.039 -0.982 . . . . 2.26 110.581 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.424 -0.798 . . . . 3.25 109.991 177.131 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.5 t60 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.346 -0.242 . . . . 6.01 110.346 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -167.72 -87.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.703 0.287 . . . . 1.95 110.622 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.529 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p -152.07 54.77 1.37 Allowed Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 121.842 0.83 . . . . 1.79 110.949 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 10.3 Cg_endo -88.28 8.07 4.22 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.024 2.483 . . . . 0.61 112.487 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 m 57.37 29.16 16.46 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.441 -0.799 . . . . 1.41 111.062 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 7' ' ' PRO . . . -99.8 -94.65 2.11 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.819 -0.705 . . . . 0.45 112.499 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 6' ' ' GLY . 16.7 Cg_exo -68.85 56.26 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.529 2.819 . . . . 1.75 113.436 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 t-20 51.38 62.64 10.84 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.534 -0.757 . . . . 2.07 112.077 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -87.14 -61.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.697 2.265 . . . . 0.75 110.659 171.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.25 -21.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.578 -0.737 . . . . 1.75 110.213 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.3 m -158.44 148.17 19.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.883 -0.599 . . . . 2.26 109.937 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.41 ' HB3' HD22 ' A' ' 8' ' ' ASN . 56.3 t30 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.408 -0.806 . . . . 3.25 110.193 172.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.731 0.301 . . . . 6.01 110.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.423 ' C ' ' HD3' ' A' ' 4' ' ' PRO . 11.1 pt-20 -101.93 -27.9 12.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.313 -0.403 . . . . 1.95 111.288 -175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.463 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 p -135.51 62.02 46.94 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 122.066 0.936 . . . . 1.79 111.022 -176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.9 Cg_endo -95.85 20.43 0.52 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.509 2.806 . . . . 0.61 112.116 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.1 m 51.08 52.7 14.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.441 -0.8 . . . . 1.41 110.977 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -135.28 -82.2 0.15 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.457 -0.878 . . . . 0.45 112.864 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.65 57.65 3.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.003 2.469 . . . . 1.75 111.963 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.449 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.1 p30 37.54 60.96 4.11 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 114.814 -1.084 . . . . 2.07 113.369 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.0 Cg_exo -76.32 -53.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.957 1.771 . . . . 0.75 109.757 173.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -135.01 -50.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.091 -0.959 . . . . 1.75 109.041 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 m -70.15 95.97 1.03 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.758 -0.656 . . . . 2.26 110.488 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.791 -0.623 . . . . 3.25 109.939 177.798 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.7 m80 . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.56 0.219 . . . . 6.01 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 29.0 tt0 -120.22 -136.86 0.33 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.035 -0.358 . . . . 1.95 110.035 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.518 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 25.0 t -135.36 61.41 44.42 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 121.312 0.577 . . . . 1.79 110.419 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 14.2 Cg_endo -99.35 28.26 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.701 2.934 . . . . 0.61 112.09 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m 52.01 46.03 27.3 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.51 -0.768 . . . . 1.41 111.131 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -124.19 -84.02 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.818 -0.706 . . . . 0.45 112.717 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.15 66.17 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.064 2.509 . . . . 1.75 112.817 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.5 p-10 37.13 55.46 3.44 Favored Pre-proline 0 N--CA 1.472 0.64 0 C-N-CA 124.629 1.172 . . . . 2.07 113.784 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.3 Cg_exo -80.71 -69.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.269 1.979 . . . . 0.75 110.893 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.73 20.61 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.23 1.014 . . . . 1.75 108.369 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ASN . 35.6 t -157.94 118.9 3.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.713 -1.13 . . . . 2.26 109.405 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.214 -0.898 . . . . 3.25 109.992 -178.54 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 63.4 t60 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.261 0.077 . . . . 6.01 110.831 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -105.56 -93.42 0.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.626 -0.43 . . . . 1.95 111.124 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 9.7 p -157.39 55.94 1.03 Allowed Pre-proline 0 CA--C 1.548 0.867 0 CA-C-O 121.651 0.739 . . . . 1.79 112.21 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 5.7 Cg_exo -79.89 6.69 5.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.528 2.152 . . . . 0.61 112.436 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.418 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 22.6 t 60.44 26.17 15.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.608 -0.724 . . . . 1.41 111.004 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.38 -89.26 1.89 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.876 -0.678 . . . . 0.45 112.209 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.23 77.52 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.011 2.474 . . . . 1.75 112.989 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 5.6 p30 35.41 58.5 2.68 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.046 1.128 . . . . 2.07 114.046 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.4 Cg_endo -88.73 -64.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.629 2.219 . . . . 0.75 111.082 174.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.7 tt -120.71 11.09 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.795 -1.187 . . . . 1.75 107.795 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -124.9 80.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.21 -1.359 . . . . 2.26 110.118 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.006 -0.997 . . . . 3.25 110.515 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.645 -0.502 . . . . 6.01 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -121.32 -99.38 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.394 -0.366 . . . . 1.95 110.373 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.495 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 21.7 t -146.79 60.48 5.92 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 120.983 0.42 . . . . 1.79 110.131 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 6.3 Cg_endo -91.23 1.68 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.819 2.346 . . . . 0.61 112.256 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' SER . 45.8 m 60.35 20.38 9.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.697 -0.683 . . . . 1.41 111.006 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.41 -80.96 0.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.967 -0.635 . . . . 0.45 112.183 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -68.54 -82.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.38 2.053 . . . . 1.75 113.206 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' H ' ' HD2' ' A' ' 9' ' ' PRO . 2.9 t-20 -112.05 -51.44 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 114.989 1.477 . . . . 2.07 114.989 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.758 ' HD2' ' H ' ' A' ' 8' ' ' ASN . 17.4 Cg_exo -26.64 -69.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 124.622 3.548 . . . . 0.75 114.528 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.9 mt -126.14 57.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.571 -0.9 . . . . 1.75 108.571 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' SER . 32.3 t -151.93 -40.58 0.11 Allowed 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.275 -0.875 . . . . 2.26 111.235 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 8' ' ' ASN . 25.6 t-20 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.573 -0.727 . . . . 3.25 109.967 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.0 m80 . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.47 0.176 . . . . 6.01 110.649 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 3' ' ' VAL . 7.8 tp10 -96.85 -96.55 0.2 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.166 -0.214 . . . . 1.95 110.827 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG23 ' HG3' ' A' ' 2' ' ' GLU . 47.5 t -138.6 66.28 41.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.552 0.692 . . . . 1.79 110.019 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 9.6 Cg_endo -98.89 17.27 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.839 3.026 . . . . 0.61 112.545 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t 55.65 49.51 16.28 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 115.485 -0.78 . . . . 1.41 110.257 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.2 -96.54 0.66 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.473 -0.87 . . . . 0.45 113.323 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.23 -73.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.127 2.551 . . . . 1.75 113.272 -173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.577 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 23.9 p-10 -157.96 54.35 0.76 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 112.846 0.684 . . . . 2.07 112.846 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_endo -81.65 -65.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.862 1.708 . . . . 0.75 110.38 171.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.2 tt -121.29 -9.37 9.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.4 -0.818 . . . . 1.75 109.248 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p -99.79 66.2 1.38 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.378 -0.828 . . . . 2.26 110.962 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.422 -0.799 . . . . 3.25 110.004 179.03 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 4' ' ' PRO . 83.8 m-70 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.989 -0.374 . . . . 6.01 109.989 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HG3' HG12 ' A' ' 3' ' ' VAL . 8.2 pt-20 -67.91 -48.38 66.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.33 0.863 . . . . 1.95 113.33 -169.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.4 p -139.06 58.42 12.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 121.948 0.88 . . . . 1.79 112.345 -170.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HG3' ' HB2' ' A' ' 1' ' ' HIS . 31.6 Cg_endo -101.91 14.91 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.498 2.799 . . . . 0.61 112.328 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t 59.03 31.64 21.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.443 0.64 . . . . 1.41 109.988 -172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.43 -94.12 1.63 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.44 -0.8 . . . . 0.45 113.157 -175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.65 -73.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.642 2.228 . . . . 1.75 112.451 -175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.611 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 6.6 p30 -154.87 53.22 0.83 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.156 0.428 . . . . 2.07 112.156 175.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 7.9 Cg_exo -74.94 -61.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.161 1.908 . . . . 0.75 111.254 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -125.65 -32.2 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.796 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m -117.22 80.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.031 0.382 . . . . 2.26 112.031 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.0 t30 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.695 -0.669 . . . . 3.25 109.649 172.082 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.2 m80 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.346 -0.242 . . . . 6.01 110.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -105.13 -96.41 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.738 -0.385 . . . . 1.95 110.752 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.612 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 7.9 p -162.92 47.32 0.2 Allowed Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 113.056 0.761 . . . . 1.79 113.056 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 2.9 Cg_endo -82.92 -6.8 11.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.721 1.614 . . . . 0.61 112.124 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.462 ' N ' ' HG2' ' A' ' 9' ' ' PRO . 59.0 m 58.16 22.24 8.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.412 -0.813 . . . . 1.41 111.864 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.94 -89.09 1.56 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.875 -0.679 . . . . 0.45 112.898 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.59 -79.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.074 2.516 . . . . 1.75 113.079 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 4.0 p30 -148.13 46.96 0.49 Allowed Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.939 0.718 . . . . 2.07 112.939 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 2.7 Cg_exo -78.0 -69.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.921 1.747 . . . . 0.75 110.778 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mt -109.67 -10.9 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.517 -0.92 . . . . 1.75 108.517 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 p -100.06 72.47 1.68 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.91 -1.041 . . . . 2.26 111.142 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 115.849 -0.614 . . . . 3.25 110.177 176.757 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.483 -0.562 . . . . 6.01 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -77.28 -88.43 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.997 -0.281 . . . . 1.95 111.117 -175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.611 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 8.7 p -164.31 45.03 0.12 Allowed Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 112.696 0.628 . . . . 1.79 112.696 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 3' ' ' VAL . 18.0 Cg_endo -91.13 -6.35 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.804 1.669 . . . . 0.61 112.401 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 46.43 41.89 10.0 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.139 -0.937 . . . . 1.41 112.157 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.52 -98.46 1.55 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.804 -0.712 . . . . 0.45 113.129 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.17 -73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.964 3.109 . . . . 1.75 113.588 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.598 ' N ' ' HD3' ' A' ' 9' ' ' PRO . 27.8 p-10 -156.94 55.17 0.96 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 112.001 0.371 . . . . 2.07 112.001 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 4.7 Cg_exo -81.9 -68.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.281 1.988 . . . . 0.75 110.991 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.4 mt -116.37 -42.11 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.139 -0.482 . . . . 1.75 110.547 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -55.3 -55.85 26.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.835 -0.621 . . . . 2.26 111.46 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 8' ' ' ASN . 94.3 m-20 . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.36 -0.828 . . . . 3.25 110.159 179.5 . . . . . . . . 1 1 . 1 stop_ save_